CTLT
Catalent, Inc. (CTLT)
$50.136.25%▲
Market is closedMarket is closed – opens on 8 PM, 01 Dec 2022
– opens on 8 PM, 01 Dec 2022
Key Stats
$47.435
Day's Range
$50.3
$40.69
52-Week Range
$131.42
| Returns | |
| 1 month return | 1.21% |
| 3 month return | 43.25% |
| 1 year return | 60.62% |
| 5 year return | 29.2% |
Company Information
Catalent, Inc., an S&P 500® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.
| Organization | Catalent, Inc. |
| Employees | 19000 |
| CEO | Mr. John R. Chiminski |
| Industry | Health Technology |
Analyst Recommendation
based on 12 analysts ratings
Buy
91%
Buy
8%
Hold
0%
Sell
Based on 12 Wall street analysts offering stock ratings for Catalent, Inc.(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 46.38%Current
$50.13
Target
$73.38
Recommendation Trend
Based on 12 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 11 | 20 | 20 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 8.5B |
| Book Value | $26.11 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | 2.36 |
| PE Ratio | 19.99 |
| PEG Ratio | 1.05 |
| Wall Street Target Price | 73.38 |
Valuation
| Trailing PE | 19.99 |
| Forward PE | 11.79 |
| Price/Book (mrq) | 1.58 |
| Enterprise Value | 11.3B |
| Enterprise Value/Revenue | 2.35 |
| Enterprise Value/Ebitda | 10.99 |
Technicals
| Beta | 1.3 |
| 50 Day MA | 62.14 |
| 200 Day MA | 92.25 |
Institutional Holdings
T. Rowe Price Associates, Inc.
12.39%
Vanguard Group Inc
10.68%
Capital World Investors
6.34%
State Street Corporation
3.96%
Veritas Asset Management LLP
3.87%
HHG PLC
3.79%
Discover more
Frequently Asked Questions
What is Catalent, Inc. share price today?
Can Indians buy Catalent, Inc. shares?
How can I buy Catalent, Inc. shares from India?
Can Fractional shares of Catalent, Inc. be purchased?
What are the documents required to start investing in Catalent, Inc. stocks?
What are today’s High and Low prices of Catalent, Inc.?
What are today’s traded volumes of Catalent, Inc.?
What is today’s market capitalisation of Catalent, Inc.?
What is the 52 Week High and Low Range of Catalent, Inc.?
How much percentage Catalent, Inc. is down from its 52 Week High?
How much percentage Catalent, Inc. is up from its 52 Week low?
What are the historical returns of Catalent, Inc.?
Who is the Chief Executive Officer (CEO) of Catalent, Inc.?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*